BamSEC and AlphaSense Join Forces
Learn More

Ligand Pharmaceuticals Incorporated

NASDAQ: LGND    
Share price (12/20/24): $114.64    
Market cap (12/20/24): $2.166 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.3
from S-3ASR 52 pages Ligand Pharmaceuticals Incorporated Indenture Dated as of , 20 [ ] Trustee
12/34/56
EX-4.3
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from 10-K 6 pages Indenture or similar
12/34/56
EX-4.2
from 8-K 3 pages Supplemental Indenture (This “Supplemental Indenture”), Dated as of February 20, 2018, Between Ligand Pharmaceuticals Incorporated, a Delaware Corporation (The “Issuer”) and Wilmington Trust, National Association, as Trustee Under the Indenture Referred to Below (The “Trustee”)
12/34/56
EX-4.2
from 8-K ~5 pages Second Supplemental Indenture (This “Second Supplemental Indenture”), Dated as of May 22, 2018, Between Ligand Pharmaceuticals Incorporated, a Delaware Corporation (The “Company”), and Wilmington Trust, National Association, as Trustee Under the Indenture Referred to Below (The “Trustee”)
12/34/56
EX-4.1
from 8-K >50 pages Ligand Pharmaceuticals Incorporated and Wilmington Trust, National Association, as Trustee Indenture Dated as of May 22, 2018 0.75% Convertible Senior Notes Due 2023
12/34/56
EX-4.1
from 10-K 3 pages Indenture or similar
12/34/56
EX-4.1
from 8-K 101 pages Ligand Pharmaceuticals Incorporated as Issuer 0.75% Convertible Senior Notes Due 2019 Indenture Dated as of August 18, 2014 Wilmington Trust, National Association as Trustee
12/34/56
EX-4.12
from S-3ASR 47 pages Ligand Pharmaceuticals Incorporated Indenture Dated as of October 2, 2013 [Name of Trustee] Trustee
12/34/56
EX-4.1
from 8-K 4 pages First Amendment to 2006 Preferred Shares Rights Agreement June 19, 2013
12/34/56
EX-4.7
from S-3 49 pages Ligand Pharmaceuticals Incorporated Indenture Dated as of , 20 [Name of Trustee] Trustee
12/34/56
EX-4.5
from S-3 8 pages Warrant Pharmacopeia Drug Discovery, Inc. Warrants for the Purchase of Shares of Common Stock
12/34/56
EX-4.3
from S-3 18 pages Pharmacopeia Drug Discovery, Inc. Amended and Restated 2004 Stock Incentive Plan Effective April 6, 2004 Effective as Amended and Restated May , 2007 Article 1 Purpose and Term of Plan Article 2 Definitions
12/34/56
EX-4.1
from 425 4 pages Amendment to Rights Agreement
12/34/56
EX-4
from 8-A12B ~50 pages 2006 Preferred Shares Rights Agreement
12/34/56
EX-4
from 8-K ~50 pages Preferred Shares Rights Agreement
12/34/56
EX-4
from 8-A12G/A ~50 pages Indenture or similar
12/34/56
EX-4
from S-3 ~10 pages Exhibit 4.6 - Control Agreement
12/34/56
EX-4
from S-3 ~50 pages Exhibit 4.5 - Pledge Agreement
12/34/56
EX-4
from S-3 ~10 pages Exhibit 4.4 - 6% Convertible Subordinated Note
12/34/56